Dental Sedation & Obstructive Sleep Apnoea

21 Mar

Obstructive Sleep Apnoea (OSA) is a prevalent sleep disorder characterized by recurrent episodes of upper airway collapse during sleep, leading to intermittent hypoxia and sleep fragmentation (Punjabi, 2008). Patients with OSA often present with symptoms such as loud snoring, excessive daytime sleepiness, and witnessed apnoeic events. Given the increasing need for dental procedures, understanding the risks associated with dental sedation in this population is critical for patient safety.

Dental sedation, ranging from minimal to deep, is frequently used to manage anxiety and facilitate treatment. However, in patients with OSA, sedation can exacerbate airway obstruction. Sedative medications, particularly benzodiazepines and opioids, depress the central nervous system, leading to decreased muscle tone in the upper airway and reduced ventilatory drive (American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists, 2018). This can increase the frequency and duration of apneic episodes, potentially resulting in severe hypoxemia, hypercapnia, and cardiovascular complications.

The risks of dental sedation in OSA patients include an increased likelihood of airway obstruction, desaturation, and the need for airway interventions. These patients may also experience delayed recovery from sedation, prolonged post-operative monitoring, and an elevated risk of adverse events such as cardiac arrhythmias, myocardial ischemia, and stroke, particularly in those with pre-existing cardiovascular comorbidities (Apnea-Hypopnea Index, 2017).

Careful pre-operative assessment is paramount for identifying patients at risk. Screening tools such as the STOP-BANG questionnaire can aid in identifying individuals with undiagnosed OSA (Chung et al., 2008). When sedation is deemed necessary, a multidisciplinary approach involving the dental practitioner, an anesthesiologist, and potentially a sleep medicine specialist, is recommended. Tailoring the sedation regimen, using shorter-acting agents, and employing appropriate monitoring, including continuous pulse oximetry and capnography, are essential to mitigate risks. Furthermore, having reversal agents readily available and ensuring the dental team is proficient in airway management techniques are crucial for responding to potential complications. Prioritizing patient safety through thorough evaluation and careful management is key when providing dental sedation to individuals with obstructive sleep apnea.

References

American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. (2018). Practice Guidelines for Sedation and Analgesia by Non-Anesthesiologists. Anesthesiology, 128(3), 437-471.

Apnea-Hypopnea Index. (2017). In Medical Subject Headings. National Library of Medicine.

Chung, F., Yegneswaran, B., Liao, P., Chung, S. A., Vairavanathan, R., Islam, S., ... & Shapiro, C. M. (2008). STOP questionnaire: A tool to screen patients for obstructive sleep apnea. Anesthesiology, 108(5), 812-821.

Punjabi, N. M. (2008). The epidemiology of sleep apnea. Clinics in Chest Medicine, 29(4), 585-59 Punjabi, N. M. (2008). The epidemiology of sleep apnea. Clinics in Chest Medicine, 29(4), 585-596.